Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where C. J. Peters is active.

Publication


Featured researches published by C. J. Peters.


The Journal of Infectious Diseases | 1999

The Reemergence of Ebola Hemorrhagic Fever, Democratic Republic of the Congo, 1995

Ali S. Khan; F. Kweteminga Tshioko; David L. Heymann; Bernard Le Guenno; Pierre Nabeth; Barbara Kerstiëns; Yon Fleerackers; Peter H. Kilmarx; Guénaël Rodier; Okumi Nkuku; Pierre E. Rollin; Anthony Sanchez; Sherif R. Zaki; Robert Swanepoel; Oyewale Tomori; Stuart T. Nichol; C. J. Peters; Jean-Jacques Muyembe-Tamfum; Thomas G. Ksiazek

In May 1995, an international team characterized and contained an outbreak of Ebola hemorrhagic fever (EHF) in Kikwit, Democratic Republic of the Congo. Active surveillance was instituted using several methods, including house-to-house search, review of hospital and dispensary logs, interview of health care personnel, retrospective contact tracing, and direct follow-up of suspect cases. In the field, a clinical case was defined as fever and hemorrhagic signs, fever plus contact with a case-patient, or fever plus at least 3 of 10 symptoms. A total of 315 cases of EHF, with an 81% case fatality, were identified, excluding 10 clinical cases with negative laboratory results. The earliest documented case-patient had onset on 6 January, and the last case-patient died on 16 July. Eighty cases (25%) occurred among health care workers. Two individuals may have been the source of infection for >50 cases. The outbreak was terminated by the initiation of barrier-nursing techniques, health education efforts, and rapid identification of cases.


The Journal of Infectious Diseases | 1999

Transmission of Ebola Hemorrhagic Fever: A Study of Risk Factors in Family Members, Kikwit, Democratic Republic of the Congo, 1995

Scott F. Dowell; Rose Mukunu; Thomas G. Ksiazek; Ali S. Khan; Pierre E. Rollin; C. J. Peters

The surviving members of 27 households in which someone had been infected with Ebola virus were interviewed in order to define the modes of transmission of Ebola hemorrhagic fever (EHF). Of 173 household contacts of the primary cases, 28 (16%) developed EHF. All secondary cases had direct physical contact with the ill person (rate ratio [RR], undefined; P < .001), and among those with direct contact, exposure to body fluids conferred additional risk (RR, 3.6; 95% confidence interval [CI], 1.9-6.8). After adjusting for direct contact and exposure to body fluids, adult family members, those who touched the cadaver, and those who were exposed during the late hospital phase were at additional risk. None of the 78 household members who had no physical contact with the case during the clinical illness were infected (upper 95% CI, 4%). EHF is transmitted principally by direct physical contact with an ill person or their body fluids during the later stages of illness.


The Journal of Infectious Diseases | 1999

Clinical Virology of Ebola Hemorrhagic Fever (EHF): Virus, Virus Antigen, and IgG and IgM Antibody Findings among EHF Patients in Kikwit, Democratic Republic of the Congo, 1995

T. G. Ksiazek; Pierre E. Rollin; A. J. Williams; David S. Bressler; Mary Lane Martin; R. Swanepoel; F. J. Burt; P. A. Leman; Ali S. Khan; Alexander K. Rowe; Rose Mukunu; Anthony Sanchez; C. J. Peters

Ebola hemorrhagic fever (EHF) patients treated at Kikwit General Hospital during the 1995 outbreak were tested for viral antigen, IgG and IgM antibody, and infectious virus. Viral antigen could be detected in virtually all patients during the acute phase of illness, while antibody was not always detectable before death. Virus was also isolated from patients during the course of their febrile illness, but attempts to quantify virus in Vero E6 cells by standard plaque assay were often unsuccessful. IgG and IgM antibody appeared at approximately the same time after disease onset (8-10 days), but IgM persisted for a much shorter period among the surviving convalescent patients. IgG antibody was detectable in surviving patients through about 2 years after onset, the latest time that samples were obtained. Detection of Ebola virus antigens or virus isolation appears to be the most reliable means of diagnosis for patients with suspected acute EHF, since patients with this often-fatal disease (80% mortality) may not develop detectable antibodies before death.


Emerging Infectious Diseases | 1999

Long-term studies of hantavirus reservoir populations in the southwestern United States: a synthesis.

James N. Mills; Thomas G. Ksiazek; C. J. Peters; James E. Childs

A series of intensive, longitudinal, mark-recapture studies of hantavirus infection dynamics in reservoir populations in the southwestern United States indicates consistent patterns as well as important differences among sites and host-virus associations. All studies found a higher prevalence of infection in older (particularly male) mice; one study associated wounds with seropositivity. These findings are consistent with horizontal transmission and transmission through fighting between adult male rodents. Despite very low rodent densities at some sites, low-level hantavirus infection continued, perhaps because of persistent infection in a few long-lived rodents or periodic reintroduction of virus from neighboring populations. Prevalence of hantavirus antibody showed seasonal and multiyear patterns that suggested a delayed density-dependent relationship between prevalence and population density. Clear differences in population dynamics and patterns of infection among sites, sampling periods, and host species underscore the importance of replication and continuity of long-term reservoir studies. Nevertheless, the measurable associations between environmental variables, reservoir population density, rates of virus transmission, and prevalence of infection in host populations may improve our capacity to model processes influencing infection and predict increased risk for hantavirus transmission to humans.


The Journal of Infectious Diseases | 1999

Epidemiology of Ebola (Subtype Reston) Virus in the Philippines, 1996

M. E. Miranda; T. G. Ksiazek; T. J. Retuya; Ali S. Khan; Anthony Sanchez; Charles F. Fulhorst; Pierre E. Rollin; A. B. Calaor; D. L. Manalo; M. C. Roces; M. M. Dayrit; C. J. Peters

Ebola (subtype Reston [EBO-R]) virus infection was detected in macaques imported into the United States from the Philippines in March 1996. Studies were initiated in the Philippines to identify the source of the virus among monkey-breeding and export facilities, to establish surveillance and testing, and to assess the risk and significance of EBO-R infections in humans who work in these facilities. Over a 5-month period, acutely infected animals were found at only one facility, as determined using Ebola antigen detection. Three of 1732 monkeys and 1 of 246 animal handlers tested had detectable antibodies; all were from the same facility, which was the source of infected monkeys imported to the United States. Virus transmission, which was facilitated by poor infection-control practices, continued for several months in one facility and was stopped only when the facility was depopulated. None of the 246 employees of the facilities or 4 contacts of previously antibody-positive individuals reported an Ebola-like illness. This investigation suggests that human EBO-R infection is rare.


Journal of Medical Virology | 1999

Genetic investigation of novel hantaviruses causing fatal HPS in Brazil

Angela M. Johnson; Luiza Terezinha Madia de Souza; Ivani Bisordi Ferreira; Luiz Eloy Pereira; Thomas G. Ksiazek; Pierre E. Rollin; C. J. Peters; Stuart T. Nichol

Although hantavirus pulmonary syndrome (HPS) was discovered in North America in 1993, more recent investigations have shown that the disease is a much larger problem in South America, where a greater number of cases and HPS‐associated viruses have now been detected. Here we describe the genetic investigation of three fatal HPS cases from Brazil, including a 1995 case in Castelo dos Sonhos (CAS) in the state of Mato Grosso and two 1996 cases in the counties of Araraquara (ARA) and Franca (FRA), in the state of São Paulo. Reverse transcription‐polymerase chain reaction (RT‐PCR) products representing fragments of the hantavirus N, G1, and G2 coding regions were amplified from patient acute‐phase serum samples, and the nucleotide (nt) sequences (394, 259, and 139 nt, respectively) revealed high deduced amino acid sequence identity between ARA and FRA viruses (99.2%, 96.5%, and 100%, respectively). However, amino acid differences of up to 14.0% were observed when ARA and FRA virus sequences were compared with those of the geographically more distant CAS virus. Analysis of a 643‐nt N coding region and a 1734‐nt predominantly G2‐encoding region of ARA and CAS virus genomes confirmed that these Brazilian viruses were distinct and monophyletic with previously characterized Argentinean hantaviruses, and suggested that Laguna Negra (LN) virus from Paraguay was ancestral to both the Brazilian and Argentinean viruses. The phylogenetic tree based on the N coding fragment also placed LN in a separate clade with Rio Mamore virus from Bolivia. At the amino acid level, ARA and CAS viruses appeared more closely related to the Argentinean viruses than they were to each other. Similarly, analysis of the diagnostic 139‐nt G2 fragment showed that the Juquitiba virus detected in a 1993 fatal HPS case close to São Paulo city, Brazil was closer to Argentinean viruses than to ARA or CAS viruses. These data indicate that at least three different hantavirus genetic lineages are associated with Brazilian HPS cases. J. Med. Virol. 59:527–535, 1999.


Emerging Infectious Diseases | 1999

Long-Term Studies of Hantavirus Reservoir Populations in the Southwestern United States: Rationale, Potential, and Methods

James N. Mills; Terry L. Yates; Thomas G. Ksiazek; C. J. Peters; James E. Childs

Hantaviruses are rodent-borne zoonotic agents that cause hemorrhagic fever with renal syndrome in Asia and Europe and hantavirus pulmonary syndrome (HPS) in North and South America. The epidemiology of human diseases caused by these viruses is tied to the ecology of the rodent hosts, and effective control and prevention relies on a thorough understanding of host ecology. After the 1993 HPS outbreak in the southwestern United States, the Centers for Disease Control and Prevention initiated long-term studies of the temporal dynamics of hantavirus infection in host populations. These studies, which used mark-recapture techniques on 24 trapping webs at nine sites in the southwestern United States, were designed to monitor changes in reservoir population densities and in the prevalence and incidence of infection; quantify environmental factors associated with these changes; and when linked to surveillance databases for HPS, lead to predictive models of human risk to be used in the design and implementation of control and prevention measures for human hantavirus disease.


The Journal of Infectious Diseases | 1999

Ebola (Subtype Reston) Virus among Quarantined Nonhuman Primates Recently Imported from the Philippines to the United States

Pierre E. Rollin; R. Joel Williams; David S. Bressler; Stephen Pearson; Mark Cottingham; George Pucak; Anthony Sanchez; Sam G. Trappier; Robert L. Peters; Patricia W. Greer; Sherif R. Zaki; Thomas A. DeMarcus; Katherine A. Hendricks; Mike Kelley; Diane M Simpson; Thomas W. Geisbert; Peter B. Jahrling; C. J. Peters; Thomas G. Ksiazek

In April 1996, laboratory testing of imported nonhuman primates (as mandated by quarantine regulations) identified 2 cynomolgus macaques (Macaca fascicularis) infected with Ebola (subtype Reston) virus in a US-registered quarantine facility. The animals were part of a shipment of 100 nonhuman primates recently imported from the Philippines. Two additional infected animals, who were thought to be in the incubation phase, were identified among the remaining 48 animals in the affected quarantine room. The other 50 macaques, who had been held in a separate isolation room, remained asymptomatic, and none of these animals seroconverted during an extended quarantine period. Due to the rigorous routine safety precautions, the facility personnel had no unprotected exposures and remained asymptomatic, and no one seroconverted. The mandatory quarantine and laboratory testing requirements, put in place after the original Reston outbreak in 1989-1990, were effective for detecting and containing Ebola virus infection in newly imported nonhuman primates and minimizing potential human transmission.


Proceedings of the National Academy of Sciences of the United States of America | 2002

Satellite imagery characterizes local animal reservoir populations of Sin Nombre virus in the southwestern United States

Gregory E. Glass; Terry L. Yates; Joshua B. Fine; Timothy Shields; John B. Kendall; Andrew G. Hope; Cheryl A. Parmenter; C. J. Peters; Thomas G. Ksiazek; Chung Sheng Li; Jonathan A. Patz; James N. Mills

The relationship between the risk of hantaviral pulmonary syndrome (HPS), as estimated from satellite imagery, and local rodent populations was examined. HPS risk, predicted before rodent sampling, was highly associated with the abundance of Peromyscus maniculatus, the reservoir of Sin Nombre virus (SNV). P. maniculatus were common in high-risk sites, and populations in high-risk areas were skewed toward adult males, the subclass most frequently infected with SNV. In the year after an El Niño Southern Oscillation (ENSO), captures of P. maniculatus increased only in high-risk areas. During 1998, few sites had infected mice, but by 1999, 18/20 of the high-risk sites contained infected mice and the crude prevalence was 30.8%. Only 1/18 of the low-risk sites contained infected rodents, and the prevalence of infection was lower (8.3%). Satellite imagery identified environmental features associated with SNV transmission within its reservoir population, but at least 2 years of high-risk conditions were needed for SNV to reach high prevalence. Areas with persistently high-risk environmental conditions may serve as refugia for the survival of SNV in local mouse populations.


The Journal of Infectious Diseases | 1999

Recombinant human monoclonal antibodies to Ebola virus.

Toshiaki Maruyama; Paul Parren; Anthony Sanchez; Irma Rensink; Luis L. Rodriguez; Ali S. Khan; C. J. Peters; Dennis R. Burton

Human Fab (IgG1kappa) phage display libraries were constructed from bone marrow RNA from 2 donors who recovered from infection with Ebola (EBO) virus during the 1995 outbreak in Kikwit, Democratic Republic of the Congo. The libraries were initially panned against a radiation-inactivated EBO virus-infected Vero cell lysate, but only weak binders were identified. In contrast, panning against secreted EBO glycoprotein (SGP) resulted in Fabs showing very strong reactivity with SGP in ELISA. These Fabs also reacted with a virion membrane preparation. The Fabs were strongly positive in IFAs with cells infected with EBO (subtype Zaire) virus but negative with uninfected cells, with a characteristic punctate staining pattern in the cytoplasm. The Fabs showed weak or no reactivity with the virus cell lysate although donor serum did react. The Fabs are now being characterized in structural and functional terms. Major interest will focus on the ability of antibodies to neutralize EBO virus and, later, to protect animals against infection.

Collaboration


Dive into the C. J. Peters's collaboration.

Top Co-Authors

Avatar

Thomas G. Ksiazek

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Pierre E. Rollin

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Stuart T. Nichol

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Ali S. Khan

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sherif R. Zaki

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Michael D. Bowen

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

T. G. Ksiazek

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Anthony Sanchez

Centers for Disease Control and Prevention

View shared research outputs
Researchain Logo
Decentralizing Knowledge